Renewable-energy company Terra Firma has announced a new large-scale solar energy build programme that will see customers gain access to wheeled energy from August 2026. The R1.3-billion programme ...

The Broad Institute of MIT and Harvard, one of the most prominent biotech research centers in ... an open-source software platform, called Terra, intended to allow scientists to work with large ...

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech ...

Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...

The Scout Traveler SUV and Terra pickup arrive in 2027 Scout said the EVs will have up to 350 miles of range; 500 miles with the range extender Pricing is said to start at under $60,000 Scout ...

Thankfully, Bertie can read the newspaper once he is on terra firma of his office. He caught sight of a news piece reporting that the fiscal deficit for the state was likely to well exceed the 3% ...

Debuting alongside its Scout Traveler SUV sibling, which we review separately, the Terra is poised to be an amalgam of modern and traditional styling and engineering themes. For instance ...

However, the biotech has what it takes to be successful in the challenging gene-editing niche. This company might be worth far more than many realize. If I had to buy one share of any biotech with ...

Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person ...